Illumina (XTER:ILU) Short Interest


XTER:ILU Illumina Inc XTER:ILU
76 GF Score
Price €124.28
GF Value €90.37
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTER:ILU vs MTD, DGX, LH: Short Interest Comparison

For the Diagnostics & Research subindustry, Illumina's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Illumina Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Short Interest distribution charts can be found below:

* The bar in red indicates where Illumina's Short Interest falls into.


XTER:ILU
76GF Score
Illumina Inc XTER:ILU
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Illumina (XTER:ILU) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of €124.28 is trading 37.5% above its estimated GF Value™ of €90.37. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for XTER:ILU:

  • Short Interest:
  • GF Value™: €90.37 vs. price of €124.28 (37.5% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XTER:ILU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
76GF Score

Get the complete analysis for XTER:ILU

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€124.28
Price
€90.37
GF Value